Refine by
Cancer Early Articles & Analysis
39 articles found
One of the key issues is drug resistance. Cancer cells often develop resistance to BCL2 inhibitors by upregulating other anti-apoptotic proteins like MCL1 or BCL-XL. ...
These changes can be used to detect cancer early and monitor the effectiveness of treatment. Furthermore, exosomes also carry small RNAs, such as microRNAs, which influence gene expression and can modulate metabolic pathways in recipient cells. ...
They are implicated in a wide range of conditions, from cardiovascular and metabolic disorders to neurological diseases and cancers. By facilitating the early stages of the drug development pipeline, GPCR Screening Services help streamline the identification of lead compounds, optimizing the chances of successful therapeutic outcomes. ...
Traditional approaches often fall short in detecting cancers early or accurately characterizing subtypes necessary for effective treatment. ...
CD BioSciences has launched new services on anti-centrosome antibody development to assist cancer preclinical research. It is committed to providing full packages from antigen synthesis to antibody generation and manufacturing. ...
CDH1 acts as a tumor suppressor by inhibiting the Wnt/β-catenin pathway, which is often dysregulated in cancer. What is the role of CDH1 in cancer? The loss or dysfunction of CDH1 has been implicated in the development and progression of various types of cancer. ...
How is nano-flow cytometry being used to improve early disease detection? Cancer detection: Nano-flow cytometry is being used by researchers to create new blood tests that can identify cancer cells in their earliest stages. As an illustration, scientists at the University of California, Los Angeles have created a brand-new blood test that can ...
According to the latest data, breast cancer has overtaken lung cancer to become the most common cancer among women, and the death rate is the second highest among female tumors, seriously affecting the physical and mental health of women around the world. ...
The antibody can be released to partially target and attach to HER2 on cancer cells, and upon entering the cancer cells, release chemotherapeutic drugs to kill the cancer cells as well as nearby cells. ...
BioMark Diagnostics Inc. is a Canadian-based cancer diagnostic company with head office located in Richmond, British Columbia and operating lab in Quebec City, Quebec. ...
Abstract We developed a series of models to predict the likelihood of recurrence and the response to chemotherapy for the personalized treatment of stage I and II colorectal cancer patients. A recurrence prediction model was developed from 235 stage I/II patients. The model successfully distinguished between high-risk and low-risk groups, with a hazard ratio of recurrence of 4.66 (p < ...
All three companies are excited to bring such a product into the market with one goal—improving early breast cancer detection. Day 2 Technical training for Datascan engineers continued on the mobile unit. ...
Cystoscopy is invasive, uncomfortable, and has limited detection capacity for some forms of bladder cancer. Nanostics’ ClarityDX Bladder test uses extracellular vesicle detection technology and machine-learning model analysis to identify the most potent disease predictors for the early detection of bladder cancer. ...
Thalidomide and its derivatives for the treatment of multiple myeloma and other conditions have demonstrated the potential of protein degraders, while ARV-471, an estrogen receptor degrader based on the drug development of thalidomide, is targeted at the early stage of breast cancer has continued to show superior performance in clinical trials. ...
Staphylococcus aureus, Haemophilus spp., Shigella spp.) or parasitic infections (pinworm, pubic lice and scabies). Itching can also be an early symptom of vulvar cancer, but this is very rare. Unusual discharge Vaginal discharge is fluid that keeps the vagina moist and clean. ...
ByJuno Bio
Bynum: As with most conditions, early detection of AMD is preferred because, when we can detect disease early, we have an opportunity to make adjustments in the hopes of changing course. ...
This is an observational cohort study looking at women, 30 years of age or older with a concern or at risk of suspected breast disease or breast cancer. The proposed study aims to examine the diagnostic performance of non-contrast MRI in breast disease by applying quantitative multiparametric MRI ...
For urologists and prostate cancer patients, early detection and treatment are critical to successful outcomes. Approximately 80%- 85% of all prostate cancers are detected in stages I, II or III. Many diagnosed at this stage will likely be disease free after 5 years, with an average 15 year survival rate of 95%.8 A missed diagnosis could be ...
VisionGate’s Non-Intrusive Testing, Patented Cell-CT Imaging and AI-Powered Cancer Detection Work Together to Deliver Early Detection of Lung Cancer. VisionGate’s mission is backed by cutting-edge technology that is designed to save lives through early detection and prevention of lung cancer. ...
Immunotherapies over the past decade have demonstrated the potential in recruiting the immune system to treat cancer, but cancer vaccine development is still in its early days. Scientists in academia and industry are investigating a slew of approaches for targeting tumors with a vaccine, though only a few have reached clinical trials. ...
ByCalviri